Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Iron Man? Scientists found a way to treat cancer with iron oxide nanoparticles
The concept is based on the interaction of resonant semiconductor iron oxide Fe2O3 nanoparticles with…
Statins may lower mortality in high-risk prostate cancer patients
Among high-risk prostate cancer patients – those with high PSA and Gleason scores of 8…
Most men do not regret their choices for prostate cancer surgery
Men with localised prostate cancer are faced with deciding among a range of options for…
Expert Review: Prehabilitation and rehabilitation by Kim Hobbs
Expert Review: Prehabilitation and rehabilitation session by Kim Hobbs, Clinical Specialist Social Worker, Department of Gynaecological Cancer, Westmead Hospital. COSA Annual Scientific…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.